SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Lee Tom Y – ‘4’ for 12/16/20 re: Pure Bioscience, Inc.

On:  Monday, 12/28/20, at 5:44pm ET   ·   For:  12/16/20   ·   Accession #:  1209191-20-65235   ·   File #:  1-14468

Previous ‘4’:  ‘4’ on 6/26/20 for 6/24/20   ·   Next:  ‘4’ on 6/22/21 for 6/16/21   ·   Latest:  ‘4’ on 8/3/23 for 8/1/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/28/20  Lee Tom Y                         4                      1:12K  Pure Bioscience, Inc.             DONNELLEY FIN… File16/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      3K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Form 4 Submission
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Lee Tom Y

(Last)(First)(Middle)
1807 SAN GABRIEL BLVD.

(Street)
SAN GABRIELCA91776

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
PURE BIOSCIENCE, INC. [ PURE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector 10% Owner
XOfficer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/16/20
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 12/16/20P 20,000A$0.665 (1)4,637,647D
Common Stock 12/17/20P 4,712A$0.654,642,359D
Common Stock 12/21/20P 7,859A$0.684,650,218D
Common Stock 12/22/20P 45,299A$0.662 (2)4,695,517D
Common Stock 12/24/20P 851A$0.654,696,368D
Common Stock 13,401,951IBy Plum Investments, L.P. (3)
Common Stock 1,000,000IBy Kamika Shay Lee Trust Dated July 1, 2019 (4)
Common Stock 1,000,000IBy Karissa Shay Lee Trust Dated July 1, 2019 (4)
Common Stock 1,000,000IBy Tessa Melody Shin Trust Dated February 12, 2020 (4)
Common Stock 717,665IBy wife
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1)  This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.66 to $0.67. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
(2)  This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $0.64 to $0.68. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
(3)  Mr. Lee is the general partner of Plum Investments, L.P., and has ultimate voting and investment control over the shares held by Plum Investments, L.P.
(4)  Mr. Lee is a trustee of the Kamika Shay Lee Trust Dated July 1, 2019, Karissa Shay Lee Trust Dated July 1, 2019 and Tessa Melody Shin Trust Dated February 12, 2020 and has voting and dispositive power with respect to these shares
Remarks:
/s/ Tom Lee 12/28/20
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Code:
    P    Open market or private purchase of non-derivative or derivative security.

Top
Filing Submission 0001209191-20-065235   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 1:09:59.1am ET